Inspectie Gezondheidszorg en Jeugd

What Inspectie Gezondheidszorg en Jeugd does

Inspectie Gezondheidszorg en Jeugd (IGJ) is the Dutch national inspectorate for healthcare and youth care, legally tasked with monitoring, promoting, and enforcing the safety and quality of care across the Netherlands and the Caribbean Netherlands (Bonaire, Sint Eustatius, Saba). It supervises a broad sector perimeter that includes mental health (ggz), primary care, hospitals, nursing homes, disability care, youth care, and the medicines supply chain, executing enforcement instruments such as aanwijzingen and last onder bestuursdwang against non-compliant providers (for example, recent sanctions against You-Zorg, All Care 4 All, and Balans Thuiszorg).

IGJ operates through a multi-channel digital infrastructure comprising the public website (igj.nl and english.igj.nl), the Mijn IGJ provider portal, the Toezichtdocumenten public portal for inspection documents, and the Landelijk Meldpunt Zorg national reporting point. Its current strategic direction is set by the IGJ Policy Plan 2024-2027, with the Jaarbeeld 2025 serving as the principal accountability instrument. Recent operational emphasis has shifted toward digital and cross-border risks, including an online pharmacy crackdown (roughly 150 websites investigated and around 40 domains deactivated) and joint enforcement work such as Operation SHIELD with Dutch Customs, which resulted in approximately 60,000 seized pills.

IGJ is funded through the budget of the Ministry of Health, Welfare and Sport (Ministerie van Volksgezondheid, Welzijn en Sport, VWS) and does not generate commercial revenue. It works within an institutional ecosystem alongside the Dutch Healthcare Authority (NZa), RIVM, the Public Prosecution Service (OM), and Customs, conducting both routine supervision and risk-based investigations triggered by the approximately 1-in-14 complaint-to-investigation conversion among incoming reports.

Name

Inspectie Gezondheidszorg en Jeugd

Legal name

Inspectie Gezondheidszorg en Jeugd

Website

https://igj.nl

Company type

Private

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Inspectie Gezondheidszorg en Jeugd (IGJ) is the Dutch national inspectorate that supervises the safety and quality of healthcare and youth care across the Netherlands and Caribbean Netherlands, funded by the Ministry of Health, Welfare and Sport.

Ownership category

akta.pro rank

Product category

Healthcare Regulatory Inspection

NAICS

Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors (92615), Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors (926150), Testing Laboratories and Services (541380)

SIC

Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Audit, Compliance Monitoring & Investigations (BPAIADAE)

akta.pro secondary industries

Public Health Laboratories & Diagnostic Oversight (BPAIAJAF), Fire & Life Safety Code Compliance Inspections & Consulting (AHJ Support) (BPABAHAJ)

Keywords

• Healthcare regulatory oversight
• Healthcare quality inspection
• Youth care supervision
• Pharmaceutical compliance
• Healthcare enforcement

Headquarters

HQ city

Utrecht

HQ country

Netherlands

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Distribution channels2 records

Marketing channels6 records

Core offering

Inspectie Gezondheidszorg en Jeugd (IGJ) is the Dutch government regulatory inspectorate that monitors and promotes the safety and quality of healthcare and youth care in the Netherlands. It conducts inspections, investigates incidents, enforces compliance through administrative sanctions (fines, directives, instructions), and combats illegal trade in medicines. The agency operates digital reporting portals (Mijn IGJ), publishes inspection reports, and oversees healthcare providers across hospitals, primary care, mental health, nursing homes, disability care, and youth services.

Product overview

Inspectie Gezondheidszorg en Jeugd operates a suite of web-based platforms and reporting systems for healthcare and youth care oversight. The core offering consists of the main Dutch (igj.nl) and English (english.igj.nl) websites providing public information and navigation to specialized portals. Mijn IGJ serves as the authenticated professional portal for submitting mandatory reports. The Toezichtdocumenten portal provides access to inspection reports and enforcement documents. The Landelijk Meldpunt Zorg handles citizen complaints about healthcare quality. Various digital reporting forms support specific submission workflows including calamity notifications, complaints procedures, and specialized youth care reporting. The organization does not offer commercial software products but provides these government oversight and reporting platforms.

Differentiator

Problem solved

Functional benefit

Products and services

• IGJ.nl Website
• English.igj.nl Website
• Mijn IGJ Portal
• Toezichtdocumenten Portal
• Landelijk Meldpunt Zorg

Quantifiable outcome

• 67 complaints received by IGJ in 2025, comparable to prior years; approximately 75% of complaints filed by patients, clients, or family members
• +3 more outcomes

Segments8 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

14 partnerships are on record, tiered major and minor.

• Nederlandse Zorgautoriteit (NZa)majorStrategic or Co-development PartnerIGJ collaborates with the Dutch Healthcare Authority (NZa) as part of inter-agency cooperation in healthcare oversight. NZa is the regulatory body for healthcare affordability and access, while IGJ focuses on quality and safety. They share information and coordinate supervision activities where mandates overlap.
• Rijksinstituut voor Volksgezondheid en Milieu (RIVM)majorStrategic or Co-development PartnerIGJ works with RIVM (National Institute for Public Health and the Environment) on matters relating to public health, pharmaceutical quality, and environmental health standards. RIVM provides scientific expertise that supports IGJ's supervisory activities.
• Autoriteit Consument & Markt (ACM)majorStrategic or Co-development PartnerIGJ cooperates with the Netherlands Authority for Consumers & Markets on market oversight issues in healthcare, including competition law aspects of healthcare provision and consumer protection in health services.
• CIBG (Centraal Informatiepunt Beroepen Gezondheidszorg)majorStrategic or Co-development PartnerIGJ collaborates with CIBG, the Central Information Unit on Healthcare Professions, which manages registries and administrative systems supporting IGJ's oversight of healthcare professionals and institutions.
• Openbaar Ministerie (OM)majorStrategic or Co-development PartnerIGJ works with the Public Prosecution Service on criminal enforcement in healthcare, including fraud, illegal trade in medicines, and other criminal matters within IGJ's jurisdiction. IGJ's special investigating officers (Boa's) operate under OM authority for criminal investigation purposes.
• Landelijk Meldpunt Internet Oplichting (LMIO) van de PolitieminorStrategic or Co-development PartnerIGJ cooperates with the Police's National Reporting Centre for Online Fraud (LMIO) on fraudulent online pharmacy websites that take money but do not deliver products. LMIO investigates and can take down fraudulent websites.
• College ter Beoordeling van Geneesmiddelen (CBG)majorStrategic or Co-development PartnerIGJ and CBG (Medicines Evaluation Board) jointly warn the public about illegal online medicine sales. CBG evaluates the safety and efficacy of medicines in the Netherlands and works with IGJ on enforcement against illegal pharmaceutical trade.
• Nederlandse Voedsel- en Warenautoriteit (NVWA)majorStrategic or Co-development PartnerIGJ works with NVWA (Dutch Food and Consumer Product Safety Authority) in combating illegal trade in medicines. NVWA is responsible for veterinary medicines, while IGJ oversees human medicinal products. They coordinate on cross-cutting enforcement issues.
• Douane (Dutch Customs)minorStrategic or Co-development PartnerIGJ collaborates with Dutch Customs (Douane) on border controls for illegal imports and exports of medicines. Joint operations such as Operation SHIELD have resulted in seizures of counterfeit medicines.
• Inspectie Justitie en Veiligheid (Inspectie J&V)majorStrategic or Co-development PartnerIGJ and the Inspection of Justice and Security jointly supervise the youth care sector, sharing oversight of youth protection, juvenile rehabilitation, and youth care institutions under the Jeugdwet.
• Huis voor KlokkenluidersminorStrategic or Co-development PartnerIGJ has a cooperation agreement with the House for Whistleblowers (Huis voor Klokkenluiders) to handle whistleblower reports in healthcare. The House provides advice and information to potential whistleblowers, and coordinates with IGJ on reports within its mandate.
• Inspectie van het Onderwijs (IvhO)minorStrategic or Co-development PartnerIGJ cooperates with the Education Inspectorate in the youth domain, particularly when issues span both healthcare and educational settings for children and adolescents.
• Nederlandse Arbeidsinspectie (NLA)minorStrategic or Co-development PartnerIGJ cooperates with the Dutch Labour Inspectorate in the youth care domain, sharing information and conducting joint oversight where labour conditions intersect with quality of care.
• Wmo-toezichthouder (Social Support Act Supervisor)minorStrategic or Co-development PartnerIGJ cooperates with the Social Support Act supervisor (Wmo-toezichthouder) in the youth care domain for coordinated oversight of organisations operating under multiple legal frameworks.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Others

• Rijksinstituut voor Volksgezondheid en Milieu (RIVM): Dutch National Institute for Public Health and the Environment. Provides scientific and research expertise that supports IGJ's supervisory decisions; not a regulator itself but a key enabling partner in Dutch public-health oversight.

Broad incumbents

• European Medicines Agency (EMA): EU-wide medicines regulator. Overlaps with IGJ's pharmaceutical oversight (GMP/GCP/GVP) but operates at supranational level for marketing authorisation rather than national provider supervision.
• U.S. Food and Drug Administration (FDA): U.S. federal regulator for food, drugs, medical devices, cosmetics. Broadly comparable in pharmaceutical GMP inspections, adverse event oversight, and consumer protection enforcement, though with much larger scope and budget than IGJ.
• Medicines and Healthcare products Regulatory Agency (MHRA): UK regulator for medicines, medical devices and blood components. Comparable to IGJ on the pharmaceutical GMP/GDP/GCP supervision side, with broader remit over product authorisation than IGJ's national-provider-focused role.

Direct peers

• Styrelsen for Patientsikkerhed (Danish Patient Safety Authority): Denmark's national authority for patient safety and healthcare quality. Performs comparable supervisory inspections, complaint handling, and enforcement functions across the Danish health system.
• Inspektionen för vård och omsorg (IVO): Swedish Health and Social Care Inspectorate supervising healthcare, social services, and schools. Closely mirrors IGJ's combined health-and-youth remit and statutory enforcement model in another EU jurisdiction.
• Care Quality Commission (CQC): Independent regulator of health and adult social care in England. Directly comparable to IGJ in scope (quality and safety oversight across hospitals, mental health, social care), statutory enforcement powers, and public-facing reporting infrastructure.
• Statens helsetilsyn (Norwegian Board of Health Supervision): Norway's national supervisory authority for health and care services. Comparable regulatory mandate over healthcare quality and patient safety, with statutory inspection powers similar to IGJ.

Regional players

• Nederlandse Zorgautoriteit (NZa): Dutch Healthcare Authority focused on affordability, accessibility, and market regulation of healthcare. Complementary to IGJ's quality-and-safety mandate; both agencies formally cooperate on healthcare oversight in the Netherlands.
• Inspectie Justitie en Veiligheid (Inspectie J&V): Dutch Inspection of Justice and Security. Co-supervises the youth care sector with IGJ under the Jeugdwet, making it a close domain-overlap partner for the youth portion of IGJ's remit.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/igj
• Instagraminstagram.com/igjnl
• Xx.com/igjnl

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Inspectie Gezondheidszorg en Jeugd